The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Oxford/AstraZeneca COVID-19 vaccine in Nigeria.
Professor Mojisola Adeyeye, Director-General of NAFDAC, made this known in a press conference on Thursday morning, saying the agency received the dossier of the vaccine a week ago, and the organisation’s safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
The DG also said that there were three additional vaccines undergoing evaluation and that that the agency has over 30 herbal medicine undergoing review for listing.
Prof. Adeyeye said the evaluation of the Oxford AstraZeneca vaccine showed that the vaccine was effective against the UK variant of the virus which has been reported in Nigeria. She further added that there has been no reported case of the South African variant of the virus in Nigeria
She also said that the vaccine can be stored at 2 to 8-degree centigrade
The approved vaccines are being produced by the Serum Institute of India, and by SKBio in South Korea.
The Oxford/AstraZeneca vaccine received the WHO authorisation, after Pfizer-BioNTech vaccine.
Latest data shows that till date, 150246 cases have been confirmed, 126417 cases have been discharged and 1803 deaths have been recorded in 36 states and the Federal Capital Territory
1 Comment
Pingback: COVAX COVID-19 vaccines arrive in Nigeria | Innovation Village | Technology, Product Reviews, Business